HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Prednisolone therapy for Kawasaki disease].

Abstract
Prednisolone therapy for acute phase Kawasaki disease had been considered to be controversial for several decades. However, recent clinical studies revealed that prednisolone therapy might improve coronary and clinical outcomes. The present paper reviews the roles of prednisolone therapy for acute phase Kawasaki disease patients.
AuthorsTohru Kobayashi, Tomio Kobayashi, Hirokazu Arakawa
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 72 Issue 9 Pg. 1623-8 (Sep 2014) ISSN: 0047-1852 [Print] Japan
PMID25518413 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Anti-Inflammatory Agents
  • Immunoglobulins, Intravenous
  • Prednisolone
Topics
  • Acute Disease
  • Anti-Inflammatory Agents (therapeutic use)
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Mucocutaneous Lymph Node Syndrome (drug therapy)
  • Prednisolone (therapeutic use)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: